These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Flow cytometric analysis of the DNA content of adenocarcinoma of the lung, especially for patients with stage 1 disease with long term follow-up. Tanaka I; Masuda R; Furuhata Y; Inoue M; Fujiwara M; Takemura T Cancer; 1995 May; 75(10):2461-5. PubMed ID: 7736389 [TBL] [Abstract][Full Text] [Related]
10. [Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance]. Liewald F; Sunder-Plassmann L; Valet G; Wulf G; Weiss M; Schildberg FW Chirurg; 1992 Mar; 63(3):205-10. PubMed ID: 1313755 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Isobe H; Miyamoto H; Shimizu T; Haneda H; Hashimoto M; Inoue K; Mizuno S; Kawakami Y Cancer; 1990 Mar; 65(6):1391-5. PubMed ID: 2155055 [TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung. Sahin AA; Ro JY; el-Naggar AK; Lee JS; Ayala AG; Teague K; Hong WK Cancer; 1990 Feb; 65(3):530-7. PubMed ID: 2153432 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384 [TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis of cellular DNA content of lung cancer with reference to survival]. Shiota T; Konishi T; Kosaba S; Mitsuoka A; Matsubara Y; Hatakenaka R; Funatsu T; Ikeda S; Matsumoto H; Ishigami F Nihon Kyobu Geka Gakkai Zasshi; 1990 Dec; 38(12):2364-9. PubMed ID: 2290045 [TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of DNA content and proliferation and immunohistochemical staining of Ki-67 in non-small cell lung cancer. Hofmann HS; Knolle J; Bahn H; Klapperstück T; Lautenschläger C; Neef H J Cardiovasc Surg (Torino); 2001 Aug; 42(4):555-60. PubMed ID: 11455296 [TBL] [Abstract][Full Text] [Related]
16. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature]. Jeanfaivre T; Chassevent A; Larra F; Tuchais E Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603 [TBL] [Abstract][Full Text] [Related]
17. The relevance of flow-cytometric DNA content in the evaluation of lung cancer. Salvati F; Teodori L; Trinca ML; Pasquali-Lasagni R; Göhde W J Cancer Res Clin Oncol; 1994; 120(4):233-9. PubMed ID: 8288677 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer. ten Velde GP; Schutte B; Vermeulen A; Volovics A; Reynders MM; Blijham GH Eur J Cancer Clin Oncol; 1988 Mar; 24(3):455-60. PubMed ID: 2838287 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of DNA content in stage I adenocarcinoma of the lung. Roberts HL; Komaki R; Allen P; El-Naggar AK Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):573-8. PubMed ID: 9635704 [TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment. Prognostic implications. Salvati F; Teodori L; Gagliardi L; Signora M; Aquilini M; Storniello G Chest; 1989 Nov; 96(5):1092-8. PubMed ID: 2553342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]